minoxidil has been researched along with Neoplasms in 11 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of minoxidil (MXD) ethanolic solutions (1%-5% w/v) in the treatment of androgenetic alopecia is limited by adverse reactions." | 7.96 | The hydroxypropyl-β-cyclodextrin-minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia. ( Cutrignelli, A; Denora, N; Fontana, S; Franco, M; la Forgia, F; Laquintana, V; Lopedota, AA; Maqoud, F; Mele, A; Passantino, G; Scala, R; Tinelli, A; Tricarico, D; Zizzo, N, 2020) |
| "The efficacy of minoxidil (MXD) ethanolic solutions (1%-5% w/v) in the treatment of androgenetic alopecia is limited by adverse reactions." | 3.96 | The hydroxypropyl-β-cyclodextrin-minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia. ( Cutrignelli, A; Denora, N; Fontana, S; Franco, M; la Forgia, F; Laquintana, V; Lopedota, AA; Maqoud, F; Mele, A; Passantino, G; Scala, R; Tinelli, A; Tricarico, D; Zizzo, N, 2020) |
| "Thus, in patients with cancer, alopecia can be iatrogenic (chemotherapies, endocrine therapies, targeted therapies, immunotherapies, radiotherapy, surgery) or directly the consequence of the disease itself (malnutrition, scalp metastases, paraneoplastic syndromes)." | 2.72 | [Alopecia and cancers: From basics to clinical practice]. ( Baussard, L; Fiteni, F; Guichard, A; Le Vigouroux, S; Quesada, S, 2021) |
| "Alopecia is mostly reversible, but permanent damage can occur depending on the type, overall length, and dose of oncological treatment and other factors." | 2.61 | Alopecia and Hair Damage Induced by Oncological Therapy. ( Jedličková, H; Malečková, A; Vojtíšek, R; Vokurka, S, 2019) |
| "Fortunately, chemotherapy-induced hair loss is mostly reversible, and appropriate hair and scalp care and temporarily wearing a wig may be the most effective coping strategy." | 2.46 | Chemotherapy-induced alopecia. ( Trüeb, RM, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Diamandis, P | 1 |
| Wildenhain, J | 1 |
| Clarke, ID | 1 |
| Sacher, AG | 1 |
| Graham, J | 1 |
| Bellows, DS | 1 |
| Ling, EK | 1 |
| Ward, RJ | 1 |
| Jamieson, LG | 1 |
| Tyers, M | 1 |
| Dirks, PB | 1 |
| Lin, R | 1 |
| Elf, S | 1 |
| Shan, C | 1 |
| Kang, HB | 1 |
| Ji, Q | 1 |
| Zhou, L | 1 |
| Hitosugi, T | 1 |
| Zhang, L | 1 |
| Zhang, S | 1 |
| Seo, JH | 1 |
| Xie, J | 1 |
| Tucker, M | 1 |
| Gu, TL | 1 |
| Sudderth, J | 1 |
| Jiang, L | 1 |
| Mitsche, M | 1 |
| DeBerardinis, RJ | 1 |
| Wu, S | 1 |
| Li, Y | 1 |
| Mao, H | 1 |
| Chen, PR | 1 |
| Wang, D | 1 |
| Chen, GZ | 1 |
| Hurwitz, SJ | 1 |
| Lonial, S | 1 |
| Arellano, ML | 1 |
| Khoury, HJ | 1 |
| Khuri, FR | 1 |
| Lee, BH | 1 |
| Lei, Q | 1 |
| Brat, DJ | 1 |
| Ye, K | 1 |
| Boggon, TJ | 1 |
| He, C | 1 |
| Kang, S | 1 |
| Fan, J | 1 |
| Chen, J | 1 |
| Minta, A | 1 |
| Park, C | 1 |
| Rose, L | 1 |
| Trovato, S | 1 |
| Dulmage, B | 1 |
| Jedličková, H | 1 |
| Vokurka, S | 1 |
| Vojtíšek, R | 1 |
| Malečková, A | 1 |
| Maqoud, F | 1 |
| Zizzo, N | 1 |
| Mele, A | 1 |
| Denora, N | 1 |
| Passantino, G | 1 |
| Scala, R | 1 |
| Cutrignelli, A | 1 |
| Tinelli, A | 1 |
| Laquintana, V | 1 |
| la Forgia, F | 1 |
| Fontana, S | 1 |
| Franco, M | 1 |
| Lopedota, AA | 1 |
| Tricarico, D | 1 |
| Quesada, S | 1 |
| Guichard, A | 1 |
| Le Vigouroux, S | 1 |
| Baussard, L | 1 |
| Fiteni, F | 1 |
| Chen, YF | 2 |
| Chen, LH | 1 |
| Yeh, YM | 1 |
| Wu, PY | 1 |
| Chang, LY | 1 |
| Chang, JY | 1 |
| Shen, MR | 1 |
| Trüeb, RM | 1 |
| Bergstrom, KG | 1 |
| Rodriguez, R | 1 |
| Machiavelli, M | 1 |
| Leone, B | 1 |
| Romero, A | 1 |
| Cuevas, MA | 1 |
| Langhi, M | 1 |
| Romero Acuña, L | 1 |
| Romero Acuña, J | 1 |
| Amato, S | 1 |
| Barbieri, M | 1 |
| Rehnlund, SO | 1 |
4 reviews available for minoxidil and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; | 2015 |
Alopecia and Hair Damage Induced by Oncological Therapy.
Topics: Alopecia; Antineoplastic Agents; Humans; Minoxidil; Neoplasms; Radiotherapy | 2019 |
[Alopecia and cancers: From basics to clinical practice].
Topics: Alopecia; Antihypertensive Agents; Antineoplastic Agents; Bimatoprost; Hair; Hair Follicle; Humans; | 2021 |
Chemotherapy-induced alopecia.
Topics: Alopecia; Antineoplastic Agents; Female; Hair Follicle; Humans; Male; Minoxidil; Neoplasms; Scalp; V | 2010 |
1 trial available for minoxidil and Neoplasms
| Article | Year |
|---|---|
Minoxidil (Mx) as a prophylaxis of doxorubicin--induced alopecia.
Topics: Adult; Aged; Alopecia; Double-Blind Method; Doxorubicin; Female; Humans; Middle Aged; Minoxidil; Neo | 1994 |
6 other studies available for minoxidil and Neoplasms
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic | 2007 |
Retrospective review of oral and topical minoxidil for cancer treatment-induced hair loss.
Topics: Administration, Topical; Alopecia; Hair; Humans; Minoxidil; Neoplasms; Retrospective Studies; Treatm | 2023 |
The hydroxypropyl-β-cyclodextrin-minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Topical; Alopecia; Animals; Blood Pressure; Elect | 2020 |
Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy.
Topics: Alopecia; Animals; Antineoplastic Agents, Phytogenic; Calcium; Cell Line, Tumor; Disease Models, Ani | 2017 |
What's new in androgenetic alopecia: approvals, long-term safety data, cancer risk and treatment options for women.
Topics: Alopecia; Azasteroids; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Dutasteride; | 2011 |
[Regaine again. A carcinogen?].
Topics: Carcinogens; Carcinoma, Squamous Cell; Humans; Male; Minoxidil; Neoplasms | 1989 |